학술논문

Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial
Document Type
Article
Source
In Annals of Oncology January 2018 29(1):178-185
Subject
Language
ISSN
0923-7534